A
Adverum Biotech
8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Org chart
Laurent Fischer
President & CEO
Collapse
Star Seyedkazemi
Chief Development Officer
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
Jason L. Mitchell
Chief Commercial Officer
John Rakow
Senior Legal Advisor
Dena House
SVP, Human Resources, Organizational Development & Learning
Carla Fiankan
SVP, Regulatory Affairs
Heikki Jouttijärvi
SVP & Head, Technical Operations
Bill Tan
SVP & Head, Global Clinical Operations
Adam Turpcu
Svp, Clinical Development
Aneta Ferguson
Svp, General Counsel
Soo Hong
Member, Board Of Directors And Compensation Committee
Board & advisors
James Scopa
Director
Mark Lupher
Director
Patrick Machado
Director
Dawn Svoronos
Director
Rabia Gurses Ozden
Director
Jeffrey Heier
Scientific Advisor
C. David Nicholson
Director
Teams
Offices
Similar companies
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
2 followers
Gilead Sciences
148 followers
Regeneron
111 followers
Illumina
76 followers
Agilent Technologies
77 followers
Verily Life Sciences
41 followers
Alexion Pharmaceuticals
40 followers
Explore companies